Resources

Enhancing Lentiviral Transduction Efficiency and Reducing MOI in Therapeutically Relevant Cell Types Using Small Molecule Viral Sensitizers
October 2nd, 2025PosterCell & Gene Therapies
Optimizing AAV Production Efficiency: A Scalable Approach Using Small Molecule Viral Sensitizers
October 2nd, 2025PosterCell & Gene Therapies
Optimization of Zika Vaccine Production Using Small-Molecule Viral Sensitizers to Enhance Yields
July 17th, 2025ArticleVaccines
Regulatory and Scale-up Support: With You Every Step of the Journey!
June 19th, 2025VideoCell & Gene Therapies, Vaccines
Purpose-built VSEs for VPC 2.0 and FectoVIR® Combination Platforms
June 19th, 2025VideoCell & Gene Therapies
Maximize Viral Yields with Virica’s Curated VSE™ Library
June 19th, 2025VideoCell & Gene Therapies, Vaccines
The Virica Advantage: Rapidly Maximize Viral Yields and Cut Production Costs
June 19th, 2025VideoCell & Gene Therapies, Vaccines
Rapidly Optimizing Viral Vector Production Without Process Disruption
June 19th, 2025VideoCell & Gene Therapies, Vaccines
Small Molecule Antagonists of Cellular Innate Immunity for Enhanced Cell and Gene Therapy Manufacturing
June 14th, 2025PosterCell & Gene Therapies
Optimizing AAV Production: Accelerating Discovery of Small Molecule Enhancers using High Throughput Virology and Design of Experiments
May 10th, 2025PosterCell & Gene Therapies

Virica uses cookies to provide a better website experience of our website. I agree to the Privacy Policy and Terms of Use. OK